Abstract
To the Editor.— According to Koranda et al, 1 for patients receiving immunosuppressive therapy, the incidence of herpes simplex is 35% and the incidence of herpes zoster is 13%. It is further noted that skin complications in transplant patients range from minor annoyances to life-threatening conditions. It has been my good fortune to become acquainted with glutaraldehyde, a cold sterilant, which is better than 11 others used for that purpose. 2 In reading the literature on this chemical, I was struck by the ability of 2% buffered glutaraldehyde to completely inhibit herpes simplex within ten minutes, in addition to its bactericidal, tuberculocidal, and pseudomonacidal effects. 3 I have reported a series of 12 patients with herpes simplex and four cases of herpes zoster very effectively treated, after informed consent, with 2% alkaline-buffered glutaraldehyde. 4 Prior and subsequent experiences with this chemical have been favorable. As an analogue of formaldehyde,
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
